BAS Stock Analysis: BASF SE | XETRA
Chemicals | XETRA, Germany | Market Cap: 46.731m EUR | 12M Return: 30.5% | DE000BASF111 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 93.2M
EPS Trend: 84.9%
Qual. Beats: 3
Rev. Trend: -82.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BASF SE is a German-headquartered global chemical company founded in 1865, operating across six business segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The companys portfolio spans the full chemical value chain, from petrochemicals and intermediates at the upstream end to specialized downstream offerings such as automotive coatings, battery materials, crop protection products, and ingredients for nutrition and personal care applications. BASF also has activities in commodity and renewable energy trading, engineering, and rental/leasing, with its headquarters located in Ludwigshafen am Rhein, Germany.
The company operates in the Commodity Chemicals sub-industry within the Materials sector, a segment characterized by high capital intensity, exposure to feedstock (oil and gas) price cycles, and demand that tends to track global industrial activity. Its broad product mix-covering industrial intermediates, specialty additives, and consumer-oriented chemicals-reflects a common strategy among large integrated chemical producers to balance higher-volume, price-sensitive commodity output with more differentiated, margin-stable specialty lines.
- European natural gas costs squeeze Ludwigshafen Verbund margins
- Agricultural Solutions faces generic crop protection pricing pressure
- China chemical demand weakness pressures volumes and segment earnings
| Net Income: 5.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 1.07 > 1.0 |
| NWC/Revenue: 26.59% < 20% (prev 25.40%; Δ 1.19% < -1%) |
| CFO/TA 0.06 > 3% & CFO 4.46b > Net Income 5.79b |
| Net Debt (18.2b) to EBITDA (7.78b): 2.34 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (859.2m) vs 12m ago -3.73% < -2% |
| Gross Margin: 23.80% > 18% (prev 25.43%; Δ -1.62% > 0.5%) |
| Asset Turnover: 81.36% > 50% (prev 81.58%; Δ -0.22% > 0%) |
| Interest Coverage Ratio: 3.77 > 6 (EBIT TTM 3.93b / Interest Expense TTM 1.04b) |
| A: 0.21 (Total Current Assets 35.2b - Total Current Liabilities 18.3b) / Total Assets 79.9b |
| B: 0.40 (Retained Earnings 31.8b / Total Assets 79.9b) |
| C: 0.05 (EBIT TTM 3.93b / Avg Total Assets 78.2b) |
| D: 0.87 (Book Value of Equity 36.6b / Total Liabilities 42.2b) |
| Altman-Z'' = 3.93 = AA |
| DSRI: 1.54 (Receivables 16.1b/10.3b, Revenue 63.6b/62.4b) |
| GMI: 1.07 (GM 25.43% / 23.80%) |
| AQI: 1.00 (AQ_t 0.24 / AQ_t-1 0.24) |
| SGI: 1.02 (Revenue 63.6b / 62.4b) |
| TATA: 0.02 (NI 5.79b - CFO 4.46b) / TA 79.9b) |
| Beneish M = -2.50 (Cap -4..+1) = A |
As of November 10, 2026, the stock is trading at EUR 53.85 with a total of 1,471,690 shares traded. Over the past week, the price has changed by +0.56%, over one month by +4.20%, over three months by +4.30% and over the past year by +30.54%.
Current recommended Stop Loss: 51.60 (which is 4.2% or 1.9 ATR below the current price).
BASF SE has no consensus analysts rating.
P/E Trailing = 24.1244
P/E Forward = 15.361
P/S = 0.7346
P/B = 1.2751
P/EG = 0.5906
Revenue TTM = 63.6b EUR
EBIT TTM = 3.93b EUR
EBITDA TTM = 7.78b EUR
Long Term Debt = 17.3b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.46b EUR (from shortTermDebt, last quarter)
Debt = 22.3b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.55b
Net Debt = 18.2b EUR (calculated: Debt 22.3b - CCE 4.12b)
Enterprise Value = 64.9b EUR (46.7b + Debt 22.3b - CCE 4.12b)
Interest Coverage Ratio = 3.77 (Ebit TTM 3.93b / Interest Expense TTM 1.04b)
EV/FCF = 55.45x (Enterprise Value 64.9b / FCF TTM 1.17b)
FCF Yield = 1.80% (FCF TTM 1.17b / Enterprise Value 64.9b)
FCF Margin = 1.84% (FCF TTM 1.17b / Revenue TTM 63.6b)
Net Margin = 9.09% (Net Income TTM 5.79b / Revenue TTM 63.6b)
Gross Margin = 23.80% ((Revenue TTM 63.6b - Cost of Revenue TTM 48.5b) / Revenue TTM)
Gross Margin QoQ = 21.69% (prev 25.19%)
Tobins Q-Ratio = 0.81 (Enterprise Value 64.9b / Total Assets 79.9b)
Interest Expense / Debt = 4.66% (Interest Expense 1.04b / Debt 22.3b)
Taxrate = 25.05% (729.0m / 2.91b)
NOPAT = 2.94b (EBIT 3.93b * (1 - 25.05%))
Current Ratio = 1.92 (Total Current Assets 35.2b / Total Current Liabilities 18.3b)
Debt / Equity = 0.61 (Debt 22.3b / totalStockholderEquity, last quarter 36.6b)
Debt / EBITDA = 2.34 (Net Debt 18.2b / EBITDA 7.78b)
Debt / FCF = 15.55 (Net Debt 18.2b / FCF TTM 1.17b)
Total Stockholder Equity = 35.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 5.79b / Total Assets 79.9b)
RoE = 16.48% (Net Income TTM 5.79b / Total Stockholder Equity 35.1b)
RoCE = 7.49% (EBIT 3.93b / Capital Employed (Equity 35.1b + L.T.Debt 17.3b))
RoIC = 4.75% (NOPAT 2.94b / Invested Capital 61.9b)
WACC = 5.80% (E(46.7b)/V(69.1b) * Re(6.90%) + D(22.3b)/V(69.1b) * Rd(4.66%) * (1-Tc(0.25)))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -56.29 | Cagr: -1.68%
[DCF] Terminal Value 77.97% ; FCFF base≈821.8m ; Y1≈942.1m ; Y5≈1.39b
[DCF] Fair Price = 3.09 (EV 20.9b - Net Debt 18.2b = Equity 2.66b / Shares 860.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 84.86 | EPS CAGR: 72.23% | SUE: 1.74 | # QB: 3
Revenue Correlation: -82.38 | Revenue CAGR: -3.32% | SUE: 0.59 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.30 | Chg30d=+2.36% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=3.24 | Chg30d=+7.34% | Revisions=+79% | GrowthEPS=+44.5% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=3.06 | Chg30d=+3.41% | Revisions=+0% | GrowthEPS=-5.4% | GrowthRev=+1.2%
[Analyst] Revisions Ratio: +44% (up=18, down=6)